The drugmaker launched the recall after discovering the cartridge holders can crack or break when exposed to certain chemicals, including some cleaning agents.
A broken cartridge holder may cause the insulin pen to administer a reduced medication dose, which could cause high blood sugar in patients. Novo Nordisk said the risk of such an occurrence is low.
The drugmaker shipped the affected devices to distributors, sales representatives and replacement programs between August 1, 2016 and June 22, 2017.
Novo Nordisk is informing these entities of the recall and arranging to replace the insulin pens. The drugmaker encourages patients with an affected device to check their blood sugar levels more often than usual until receiving a new cartridge holder.
More articles on supply chain:
FDA halts Merck blood cancer clinical trials after patient deaths
Britain looks to work with EU on drug regulation post-Brexit
St. Francis Medical Center receives Premier’s Supply Chain Excellence Award
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
